China National Biotech Corporation

CNBC is a research-driven biotech company that discovers, develops, manufactures and markets a broad range of human health products, including vaccines, blood derivatives, biopharmaceuticals, diagnostic reagents and others. Our products cover: HAV, HBV, MR, MMR, OPV, JEV, Rotavirus vaccine, Flu, DTap, DTwP, Tetanus, BCG, Meningococcal A+C, Albumin, Immunoglobulin, Interferon, Blood Typing reagents

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Manufacturing
- Market Research & Marketing
- Research & Development
- Sales & Distribution
- Other Industry Services

Product / Technology type(s) covered:

- Bio
- Diagnostics
- FP (finished products)
- Pharmaceuticals / Therapeutics
- Preventive
- Reagents
- Technology

Therapeutic targets:

- Epidemiology
- Infectious Diseases
- Men's Health
- Mental Health
- Women's Health

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Asia , Africa , Central/South America , North America

c. Countries active: Philippines, South Korea, Vietnam, Pakistan, Sri Lanka, Egypt, Cuba, U.S.A.

Corporate data:

Number of Employees: more than 9000

Turnover:

Amount:	Year:	Currency:
312million	2002	US Dollar

Year founded: 1919

Partners / Alliances: 1.China National Scientific Instruments & Materials Import/Export Corp.
2.China National Medical Equipment and Supplies Import/Export Corp.
3.National Vaccine & Serum Institute
4.Changchun Institute of Biological Products
5.Chengdu Institute of Biological Products
6.Lanzhou Institute of Biological Products
7.Shanghai Institute of Biological Products
8.Wuhan Institute of Biological Products